3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
19
Other
1
Gynecologic
1
Conditions
Obesity
2
Overweight
1
Inflammation
1
Infertility
1
Endometrial Neoplasms
1
Breast Neoplasms
1
Interventions
Exercise
9
exemestane
4
Psychiatric Rehabilitation
4
Tamoxifen
3
Methods
3
Metformin
3
Letrozole
3
Early Intervention, Educational
3
Diet Therapy
3
Bupropion
3
Bariatric Surgery
3
Anastrozole
3
Vitamin D
2
Therapeutics
2
Sugars
2
Specimen Handling
2
Naltrexone
2
Mammography
2
Diet, Mediterranean
2
Counseling
2
Cognitive Behavioral Therapy
2
Cholecalciferol
2
Blood Specimen Collection
2
rosiglitazone-metformin combination
1
bupropion hydrochloride, naltrexone hydrochoride drug combination
1
Yoga
1
Walking
1
Tirzepatide
1
Testosterone Propionate
1
Testosterone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Breast Neoplasms
×
Tablets
×
Other
×
Clear all
NCT06150898
2025-06-13
KePreSt
Jules Bordet Institute
Phase 2
Recruiting
112 enrolled